INHIBITION OF HIV-1 PROTEINASE BY NONPEPTIDE CARBOXYLATES

被引:19
作者
BRINKWORTH, RI
WOON, TC
FAIRLIE, DP
机构
[1] Graduate School of Science and Technology, Bond University, Gold Coast
关键词
D O I
10.1016/0006-291X(91)90915-T
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some simple dicarboxylates are among the first reported non-peptide inhibitors of HIV-1 proteinase. Only weak inhibition (IC50 ≥ 10μM) was observed but this may be significant since only two potential enzyme-binding groups are present. Dixon plots and preliminary kinetic data are reported and a possible mechanism for the inhibition is discussed. The dicarboxylates are long enough to engage the carboxylate side chains of Arg 8 and Arg 108 at either end of the 24Å long substrate-binding groove. This mode of binding has not been proven but other molecules with similarly separated charged ends are equally effective inhibitors, perhaps indicating a common mechanism of inhibition. There is evidence that placing other functional groups on the inhibitor enables alternative interactions with the enzyme which can reduce inhibitor potency. We propose that incorporation of ionic binding groups in more elaborate and selective non-peptides may potentiate inhibition of HIV-1 proteinase. © 1991.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 17 条
  • [1] FUNCTIONAL-GROUPS, DRUG RECEPTOR INTERACTIONS AND DRUG DESIGN
    ANDREWS, P
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (04) : 148 - 151
  • [2] THE 3-D STRUCTURE OF HIV-1 PROTEINASE AND THE DESIGN OF ANTIVIRAL AGENTS FOR THE TREATMENT OF AIDS
    BLUNDELL, TL
    LAPATTO, R
    WILDERSPIN, AF
    HEMMINGS, AM
    HOBART, PM
    DANLEY, DE
    WHITTLE, PJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (11) : 425 - 430
  • [3] DARKE PL, 1989, J BIOL CHEM, V264, P2307
  • [4] STRUCTURE-BASED DESIGN OF NONPEPTIDE INHIBITORS SPECIFIC FOR THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE
    DESJARLAIS, RL
    SEIBEL, GL
    KUNTZ, ID
    FURTH, PS
    ALVAREZ, JC
    DEMONTELLANO, PRO
    DECAMP, DL
    BABE, LM
    CRAIK, CS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6644 - 6648
  • [5] INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE INVITRO - RATIONAL DESIGN OF SUBSTRATE-ANALOG INHIBITORS
    DREYER, GB
    METCALF, BW
    TOMASZEK, TA
    CARR, TJ
    CHANDLER, AC
    HYLAND, L
    FAKHOURY, SA
    MAGAARD, VW
    MOORE, ML
    STRICKLER, JE
    DEBOUCK, C
    MEEK, TD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 9752 - 9756
  • [6] DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE
    ERICKSON, J
    NEIDHART, DJ
    VANDRIE, J
    KEMPF, DJ
    WANG, XC
    NORBECK, DW
    PLATTNER, JJ
    RITTENHOUSE, JW
    TURON, M
    WIDEBURG, N
    KOHLBRENNER, WE
    SIMMER, R
    HELFRICH, R
    PAUL, DA
    KNIGGE, M
    [J]. SCIENCE, 1990, 249 (4968) : 527 - 533
  • [7] FITZGERALD PMD, 1990, J BIOL CHEM, V265, P14209
  • [8] HUNIG S, 1973, ORG SYNTH, V5, P533
  • [9] HIV PROTEINASE AS A TARGET FOR DRUG-ACTION
    JOHNSTON, MI
    ALLAUDEEN, HS
    SARVER, N
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (08) : 305 - 307
  • [10] LAPATTO P, 1989, NATURE, V342, P299